@ARTICLE{
author={Howard James,Bril Vera,Vu Tuan,Karam Chafic,Peric Stojan Z,Murai Hiroyuki,Guglietta Antonio,Ulrichts Peter,Vangeneugden Tony,Utsugisawa Kimiaki,Verschuuren Jan JGM,Mantegazza Renato},
year={2021},
title={Efficacy, Safety, and Tolerability of Efgartigimod in Patients With Generalized Myasthenia Gravis: Analysis of the Phase 3 ADAPT Study},
journal={NEUROLOGY},
volume={96},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Howard James,...,Perk Stojan,...,(broj koautora 16)},
year={2021},
title={Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT) : a multicentre, randomised, placebo-controlled, phase 3 trial},
journal={LANCET NEUROLOGY},
volume={20},
number={7},
pages={526-536},
document_type={Article},
}